Jump to content

Center for Genetic Engineering and Biotechnology

Coordinates: 23°04′26″N 82°27′08″W / 23.0738°N 82.4523°W / 23.0738; -82.4523
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Rlink2 (talk | contribs) at 00:30, 3 February 2022 (→top: Adding web.archive.org links for citations with url-status=live Category:CS1_maint:_url-status). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Center for Genetic Engineering and Biotechnology

Offices of the CIGB
Research institute overview
FormedJuly 1, 1985 (1985-07-01)
Jurisdiction Cuba
HeadquartersAvenida 31 No. 15802, Havana, Cuba
23°04′26″N 82°27′08″W / 23.0738°N 82.4523°W / 23.0738; -82.4523
Websitewww.cigb.edu.cu

The Center for Genetic Engineering and Biotechnology (Template:Lang-es, CIGB) is a research institute in Havana, Cuba. It is responsible for creating the Abdala vaccine.[1][2][3]

See also

References

  1. ^ "Cuba's COVID vaccine rivals BioNTech-Pfizer, Moderna". DW.COM. 2021-06-27. Retrieved 2021-06-28.
  2. ^ "ABDALA Clinical Study - Phase III". rpcec.sld.cu. Registro Público Cubano de Ensayos Clínicos. Archived from the original on 2021-03-20. Retrieved March 22, 2021.
  3. ^ "ABDALA Clinical Study". rpcec.sld.cu. Registro Público Cubano de Ensayos Clínicos. Archived from the original on 2021-01-22. Retrieved March 22, 2021.


Stub icon

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.

Stub icon

This Cuba-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Center_for_Genetic_Engineering_and_Biotechnology&oldid=1069573149"